DeepScribe
United States
- San Francisco, CA
- 13/01/2022
- Series A
- $30,000,000
DeepScribe is an AI-powered medical scribe that captures patient encounters in real time and automates medical documentation, allowing physicians to focus on patient care instead of note-taking.
Through an enterprise-grade secure iOS app downloaded on the providers preferred device, our technology is able to listen to a patient conversation and produce a highly accurate transcription of the encounter. Next, our AI solution extracts the medically relevant information, classifies it into a standard SOAP note, and then integrates that note directly into the EHR's discrete fields.
With DeepScribe, providers can focus on delivering engaged patient care untethered from the EHR. Simply talk to a patient like normal, review your notes in your EHR at the end of the day, and sign-off.
- Industry Hospital & Health Care
- Website https://www.deepscribe.ai/
- LinkedIn https://www.linkedin.com/company/deepscribe/
Related People
Akilesh BapuCo Founder
United States -
San Francisco Bay Area
Reimagining the patient experience with voice + NLP @ DeepScribe 🩺
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)